Alexander KarpAlexander Karp earned $1B in 2024

In 2024, Kim Kelderman earned $2.29M in total compensation at Bio-Techne, including $936.00K salary and $1.32M bonus. 1+ years at the helm of Bio-Techne.

Compensation History

Annual executive compensation data for Kim Kelderman, including salary, bonuses, and stock awards.

Year

2024

Total Compensation

$2.29M

Salary

$936.00K

Bonus

$1.32M

Other

$33.47K

Salary

$936.00K

Board Justification

The Compensation Committee reviews and approves each executive’s compensation annually and is responsible for ensuring that compensation for the executive officers is consistent with four objectives: attracting and retaining superior executive talent to drive sustainable value creation, providing incentives that reward the achievement of performance goals that correlate to sustainable shareholder value, aligning executives’ incentives with long-term shareholder interests, and ensuring market competitiveness and internal equity.

Bonus

$1.32M

Board Justification

Cash performance bonuses under the Company’s Short-Term Incentive Plan based on the Company’s achievement of predetermined, objective performance targets. These challenging targets are set each year to incentivize the executives to focus on strategically important goals that directly impact the Company’s revenue and adjusted operating margin.

Other Compensation

$33.47K

Board Justification

includes $12,113 for 401(k) match, $16,890 for household security system, and $3,407 in dividends paid on unvested restricted stock, which amount was not factored into the grant date fair value of such awards.

Restricted Stock

$0.000 N/A

Board Justification

N/A

Performance Metrics

For fiscal year 2025, the annual bonus plan for most of our NEOs was again based on consolidated adjusted EBITA results and consolidated organic revenue results for the Company.

B

Kim Kelderman

CEO of Bio-Techne

Sector of Economy

Healthcare

CEO of Bio-Techne for

1 year 10 months (Feb 2024 - Present)

Previous Experience

Executive at Thermo Fisher Scientific and a Senior Segment Leader at Becton Dickinson

Holdings

Track Kim Kelderman's stock holdings and portfolio value over time.

Insider Trading

Kim Kelderman's recent stock transactions, purchases, and sales filed with the SEC.

No insider trades found for this CEO.

Rivals

Compare Kim Kelderman with competitor CEOs and industry peers.